PMC:7170415 / 22836-24590
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 350 | 933-940 | Species | denotes | persons | Tax:9606 |
| 351 | 1567-1575 | Species | denotes | patients | Tax:9606 |
| 352 | 1727-1734 | Species | denotes | persons | Tax:9606 |
| 353 | 945-953 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 354 | 1055-1064 | Disease | denotes | infection | MESH:D007239 |
| 355 | 1718-1726 | Disease | denotes | infected | MESH:D007239 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T42 | 47-51 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T22 | 47-51 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T102 | 945-953 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T103 | 1055-1064 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T208 | 32-39 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | Testing |
| T209 | 47-51 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
| T210 | 55-56 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T211 | 114-121 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T212 | 388-393 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T213 | 675-686 | http://purl.obolibrary.org/obo/OBI_0000968 | denotes | instruments |
| T214 | 698-701 | http://purl.obolibrary.org/obo/CL_0000990 | denotes | CDC |
| T215 | 733-735 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
| T216 | 795-799 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T217 | 877-881 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
| T218 | 1109-1116 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T219 | 1182-1193 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing, as |
| T220 | 1348-1355 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T221 | 1361-1364 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T222 | 1528-1535 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T223 | 1614-1621 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T34 | 11-17 | Chemical | denotes | Access | http://purl.obolibrary.org/obo/CHEBI_34922 |
| T35 | 418-426 | Chemical | denotes | reagents | http://purl.obolibrary.org/obo/CHEBI_33893 |
| T36 | 625-637 | Chemical | denotes | nucleic acid | http://purl.obolibrary.org/obo/CHEBI_33696 |
| T37 | 633-637 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T160 | 0-39 | Sentence | denotes | Scaling Up Access to Diagnostic Testing |
| T161 | 40-204 | Sentence | denotes | In the face of a public health emergency, important first steps to expand testing capacity include relaxing and streamlining regulatory requirements and procedures. |
| T162 | 205-432 | Sentence | denotes | Local public health laboratories and academic diagnostic laboratories in the United States are being rapidly enabled to perform EUA-granted commercial assays and laboratory-developed tests using research use–only reagents (61). |
| T163 | 433-602 | Sentence | denotes | University research laboratories could also add capacity, although concerns exist regarding quality control and the absence of protocols for managing clinical specimens. |
| T164 | 603-737 | Sentence | denotes | Flexibility regarding nucleic acid extraction methods and amplification instruments when using CDC protocols is being introduced (34). |
| T165 | 738-896 | Sentence | denotes | National agencies are expeditiously making materials for test development and validation available to clinical laboratories and diagnostic test manufacturers. |
| T166 | 897-1065 | Sentence | denotes | Safely evaluating clinically stable persons for COVID-19 at traditional health care access points is resource intensive and slow, and risks exposing staff to infection. |
| T167 | 1066-1296 | Sentence | denotes | Many jurisdictions are enabling innovative testing venues, such as external tents or drive-through or “phone booth” testing, as well as home assessment teams to expedite specimen collection while limiting potential exposures (62). |
| T168 | 1297-1384 | Sentence | denotes | Telemedicine combined with at-home nasal swab self-testing also has been proposed (63). |
| T169 | 1385-1576 | Sentence | denotes | Of importance, in jurisdictions without universal health care coverage, policy solutions must be introduced to eliminate financial barriers to testing for uninsured and underinsured patients. |
| T170 | 1577-1754 | Sentence | denotes | Efforts to increase accessibility of testing for multiple use cases need to be coupled to appropriate public health interventions to isolate infected persons and their contacts. |